{"id":49339,"date":"2020-01-28T12:42:53","date_gmt":"2020-01-28T10:42:53","guid":{"rendered":"https:\/\/blog.cofb.cat\/?p=49339"},"modified":"2020-01-28T12:42:53","modified_gmt":"2020-01-28T10:42:53","slug":"millorar-qualitat-presa-decisions-lanalisi-decisio-multicriteri-admc","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/es\/2020\/01\/28\/millorar-qualitat-presa-decisions-lanalisi-decisio-multicriteri-admc\/","title":{"rendered":"Mejorar en la calidad de la toma de decisiones con el an\u00e1lisis de decisi\u00f3n multicriterio (ADMC)"},"content":{"rendered":"<p>El pasado <strong>17 de enero<\/strong> tuvo lugar en <strong>Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/strong> la formaci\u00f3n <strong>&quot;An\u00e1lisis de decisi\u00f3n multicriterio&quot;<\/strong> <strong>(ADMC)<\/strong>, a cargo de <strong>Miguel \u00c1ngel Casado<\/strong>, doctor en Farmacia por la Universidad Complutense de Madrid, director de <em>Pharmacoeconomics &amp; Outcomes Research Iberia<\/em> (PORIB), profesor universitario, miembro del consejo de direcci\u00f3n del m\u00e1ster en <em>Evaluaci\u00f3n Sanitaria y Acceso al Mercado de la Universidad Carlos III de Madrid<\/em>.<\/p>\n<h1><span style=\"color: #008080;\"><strong>\u00bfQu\u00e9 objetivos ten\u00eda la sesi\u00f3n?<\/strong><\/span><\/h1>\n<p>La <strong>formaci\u00f3n<\/strong> ten\u00eda por objetivos que los participantes\u00a0<strong>asimilaran las<\/strong> <b>bases conceptuales de los an\u00e1lisis de decisi\u00f3n multicriterio (ADMC); <\/b>aprendieran cu\u00e1les son los <strong>principales m\u00e9todos de ADMC de apoyo a la toma de decisiones<\/strong> y <strong>selecci\u00f3n de intervenciones sanitarias<\/strong>; conocieran las <strong>gu\u00edas metodol\u00f3gicas internacionales sobre ADMC<\/strong>, <strong>analizaran estudios de ADMC<\/strong> publicados para revisar su dise\u00f1o, metodolog\u00eda, <strong>presentaci\u00f3n y la interpretaci\u00f3n de resultados <\/strong>y<strong>\u00a0<\/strong>se crearan un <strong>estado de opini\u00f3n<\/strong> sobre la aplicaci\u00f3n de ADMC en la <strong>toma de decisiones<\/strong> y la <strong>selecci\u00f3n de intervenciones sanitarias<\/strong>.<\/p>\n<figure id=\"attachment_49386\" aria-describedby=\"caption-attachment-49386\" style=\"width: 620px\" class=\"wp-caption aligncenter\"><a href=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2020\/01\/cofb.200117-05.jpg\"><img fetchpriority=\"high\" decoding=\"async\" class=\"wp-image-49386 size-large\" title=\"Durante la formaci\u00f3n, se trataron las bases conceptuales de los an\u00e1lisis de decisi\u00f3n multicriterio. \" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2020\/01\/cofb.200117-05-1024x683.jpg\" alt=\"Durant la formaci\u00f3, es van tractar les bases conceptuals de les an\u00e0lisis de decisi\u00f3 multicriteri. \" width=\"620\" height=\"414\" \/><\/a><figcaption id=\"caption-attachment-49386\" class=\"wp-caption-text\">Durante la formaci\u00f3n, se trataron las bases conceptuales de los an\u00e1lisis de decisi\u00f3n multicriterio.<\/figcaption><\/figure>\n<h1><span style=\"color: #008080;\"><strong>Teor\u00eda de la decisi\u00f3n<\/strong><\/span><\/h1>\n<p>Durante la sesi\u00f3n, Casado se refiri\u00f3 a la <strong>teor\u00eda de la decisi\u00f3n<\/strong>. En esta teor\u00eda, hay <strong>tres puntos importantes<\/strong>: el <strong>coste de oportunidad<\/strong>, la<strong>escasez de recursos<\/strong> y el<strong>asignaci\u00f3n eficiente de recursos<\/strong>.<\/p>\n<ul>\n<li><span style=\"color: #000000;\"><strong>Coste de oportunidad:<\/strong><\/span> Al asignar los recursos disponibles en uno <strong>programa o intervenci\u00f3n sanitaria<\/strong>, <strong>\u201csacrificamos\u201d otras oportunidades de utilizar estos recursos<\/strong>.<\/li>\n<li><span style=\"color: #000000;\"><strong>Asignaci\u00f3n eficiente de recursos:<\/strong><\/span> Las <strong>necesidades de atenci\u00f3n sanitaria (resultados en salud)<\/strong> son <strong>ilimitadas<\/strong>.<\/li>\n<li><strong>Escasez de recursos: <\/strong>Los <strong>recursos son limitados<\/strong> <strong>(insuficientes)<\/strong> para financiar todas las intervenciones.<\/li>\n<\/ul>\n<div class=\"box note\"><\/div>\n<h1><span style=\"color: #008080;\"><strong>\u00bfC\u00f3mo realizar un an\u00e1lisis de decisi\u00f3n multicriterio?<\/strong><\/span><\/h1>\n<p><span style=\"color: #333333;\">En la \u00faltima parte de la sesi\u00f3n, Casado detall\u00f3 los pasos a seguir a la hora de realizar un ADMC:<\/span><\/p>\n<p>1.- <strong>Definir el problema de decisi\u00f3n<\/strong><\/p>\n<p>2.-<strong>Seleccionar y estructurar los criterios<\/strong><\/p>\n<p>3.-<strong>Medir el valor de las alternativas<\/strong><\/p>\n<p>4.-<strong>Puntuar las alternativas<\/strong><\/p>\n<p>5.-<strong>Ponderar los criterios<\/strong><\/p>\n<p>6.-<strong>Calcular las puntuaciones agregadas<\/strong><\/p>\n<p>7.-<strong>Gestionar la incertidumbre<\/strong><\/p>\n<p>8.-<strong>Discutir los resultados<\/strong><\/p>\n<\/div>\n<h1><span style=\"color: #008080;\"><strong>Agentes decisores en la selecci\u00f3n de medicamentos\u00a0<\/strong><\/span><\/h1>\n<p>Algunos de los agentes decisores en la selecci\u00f3n de medicamentos son las <strong>Comunidades Aut\u00f3nomas<\/strong> (Servicios Regionales de Salud, Comisiones de Nuevos Medicamentos, Agencias de Evaluaci\u00f3n y Tecnolog\u00edas Sanitarias); <strong>Atenci\u00f3n Primaria<\/strong> (Comisiones de Farmacia y Terap\u00e9utica, Gerencias y Direcciones M\u00e9dicas y Servicios Cl\u00ednicos), las <strong>Sociedades Cient\u00edficas<\/strong> y los <strong>Pacientes\/Asociaciones de Pacientes<\/strong>.<\/p>\n<p>El ponente tambi\u00e9n hizo referencia a las <strong>incertidumbres<\/strong> que pueden <strong>rodear los nuevos medicamentos<\/strong> como la <strong>seguridad a largo plazo<\/strong>, la<strong>efectividad<\/strong> de las intervenciones sanitarias, el<strong>impacto presupuestario<\/strong> y la <strong>relaci\u00f3n coste-efectividad<\/strong>.<\/p>\n<h1><span style=\"color: #008080;\"><strong>Retos del Sistema Nacional de Salud<\/strong><\/span><\/h1>\n<p>Otro de los aspectos que se abordaron durante la sesi\u00f3n fueron los <strong>retos del Sistema Nacional de Salud<\/strong> como la <strong>planificaci\u00f3n<\/strong> (gesti\u00f3n de los medicamentos emergentes, planes para el abordaje de terapias avanzadas y planes estrat\u00e9gicos integrales para el abordaje de patolog\u00edas); la <strong>reducci\u00f3n de incertidumbre financiera y cl\u00ednica <\/strong>(acuerdos de techo m\u00e1ximo de gasto, precios din\u00e1micos y acuerdos de pago por resultados) y la <strong>incorporaci\u00f3n sostenible de medicamentos <\/strong>(selecci\u00f3n de subgrupos para financiaci\u00f3n).<\/p>\n<figure id=\"attachment_49384\" aria-describedby=\"caption-attachment-49384\" style=\"width: 620px\" class=\"wp-caption aligncenter\"><a href=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2020\/01\/cofb.200117-08.jpg\"><img decoding=\"async\" class=\"wp-image-49384 size-large\" title=\"El dr. Miguel \u00c1ngel Casado durante un momento de la sesi\u00f3n. \" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2020\/01\/cofb.200117-08-1024x683.jpg\" alt=\"El Dr. Miguel \u00c1ngel Casado, durant un moment de la sessi\u00f3. \" width=\"620\" height=\"414\" \/><\/a><figcaption id=\"caption-attachment-49384\" class=\"wp-caption-text\">El dr. Miguel \u00c1ngel Casado durante un momento de la sesi\u00f3n.<\/figcaption><\/figure>\n<div class=\"destacat-blog\">\n<h1><span style=\"color: #008080;\"><strong>\u00bfQu\u00e9 pueden aportar las ADMC?<\/strong><\/span><\/h1>\n<p>Otro de los aspectos que abord\u00f3 el dr. Casado durante la sesi\u00f3n fue lo que pueden aportar las <strong>an\u00e1lisis de decisi\u00f3n multicirterio<\/strong>:<\/p>\n<ul>\n<li><strong>Transparencia<\/strong>, <strong>consistencia<\/strong> y <strong>rigor<\/strong> en el proceso de toma de decisiones.<\/li>\n<li>Permite<strong> valorar m\u00faltiples criterios<\/strong> en su conjunto.<\/li>\n<li>Ayudan a <strong>segmentar un problema complejo<\/strong> en tareas m\u00e1s simples para su evaluaci\u00f3n.<\/li>\n<li>Los <strong>criterios<\/strong> pueden ser expresados utilizando cualquier medida (cualitativa, cuantitativa)<\/li>\n<li>Se pueden incorporar formalmente las <strong>preferencias de los decisores y de los influenciadores<\/strong> (pacientes, cuidadores, m\u00e9dicos, farmac\u00e9uticos, gestores, pagadores, poblaci\u00f3n en general\u2026).<\/li>\n<\/ul>\n<p>En otras palabras, explic\u00f3 que las ADMC sirven para <strong>&quot;descomponer&quot; un problema de decisi\u00f3n complejo<\/strong>, donde hay <strong>m\u00faltiples criterios que pueden estar en conflicto<\/strong> o relacionados entre s\u00ed.<\/p>\n<\/div>\n<p style=\"text-align: right;\"><strong>Actividad organizada conjuntamente con:<\/strong><\/p>\n<p style=\"text-align: right;\"><a href=\"http:\/\/www.scfarmclin.org\/\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" class=\"wp-image-47996 alignright\" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2019\/11\/SCFC.png\" alt=\"\" width=\"75\" height=\"73\" \/><\/a><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p style=\"text-align: right;\"><strong>Con el patrocinio de:<\/strong><\/p>\n<p style=\"text-align: right;\"><a href=\"https:\/\/www.daiichi-sankyo.es\/\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-49345 alignright\" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2020\/01\/Daiichi-Sankyo-1.jpg\" alt=\"\" width=\"82\" height=\"82\" \/><\/a><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Otras publicaciones de inter\u00e9s:<\/strong><\/p>\n<ul>\n<li><a href=\"https:\/\/blog.cofb.cat\/shan-prendre-decisions-sobre-salut-sessio-formativa-danalisi-decisio-multicriteri-admc\/\" target=\"_blank\" rel=\"noopener\">\u00bfC\u00f3mo tomar las decisiones sobre salud? Sesi\u00f3n formativa de an\u00e1lisis de decisi\u00f3n multicriterio (ADMC) (Octubre 2018)<\/a><\/li>\n<li><a href=\"https:\/\/blog.cofb.cat\/lab-tests-online-una-eina-per-interpretar-les-analisis-cliniques\/\" target=\"_blank\" rel=\"noopener\">Lab Tests Online: una herramienta para interpretar los an\u00e1lisis cl\u00ednicos (Junio 2017)<\/a><\/li>\n<\/ul>\n<p>&nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>El pasado 17 de enero tuvo lugar en el Colegio de Farmac\u00e9uticos de Barcelona la formaci\u00f3n &quot;An\u00e1lisis de decisi\u00f3n multicriterio&quot; (ADMC), a cargo de Miguel \u00c1ngel Casado, doctor en Farmacia por la Universidad Complutense de Madrid, director de Pharmacoeconomics &amp; Outcomes Research Iberia (PORIB), profesor universitario, miembro del consejo de [\u2026]<\/p>","protected":false},"author":1,"featured_media":49430,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[23,57],"tags":[3287,3288,18,19,53,24,68,69,480,70,853,76,59,3832,3833,3834,1018,3388,3835,3836],"class_list":["post-49339","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-destacats","category-mon-collegial","tag-admc","tag-analisi-de-decisio-multicriteri","tag-cofb","tag-collegi-de-farmaceutics-de-barcelona","tag-farmaceutics","tag-farmaceutics-comunitaris","tag-farmacia","tag-farmacia-comunitaria","tag-farmacia-hospitalaria","tag-formacio","tag-futur","tag-oficina-de-farmacia","tag-pacients","tag-presa-de-decisions","tag-proces-de-presa-de-decisions","tag-recursos","tag-reptes","tag-reptes-de-futur","tag-sistema-nacional-de-salut","tag-teoria-de-la-decisio"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Millorar en la qualitat de la presa de decisions amb l&#039;an\u00e0lisi de decisi\u00f3 multicriteri (ADMC) - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"description\" content=\"El passat 17 de gener va tenir lloc al Col\u00b7legi de Farmac\u00e8utics de Barcelona la formaci\u00f3 &quot;An\u00e0lisi de decisi\u00f3 multicriteri&quot; (ADMC).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2020\/01\/28\/millorar-qualitat-presa-decisions-lanalisi-decisio-multicriteri-admc\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Millorar en la qualitat de la presa de decisions amb l&#039;an\u00e0lisi de decisi\u00f3 multicriteri (ADMC) - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"El passat 17 de gener va tenir lloc al Col\u00b7legi de Farmac\u00e8utics de Barcelona la formaci\u00f3 &quot;An\u00e0lisi de decisi\u00f3 multicriteri&quot; (ADMC).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2020\/01\/28\/millorar-qualitat-presa-decisions-lanalisi-decisio-multicriteri-admc\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2020-01-28T10:42:53+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2020\/01\/28\/millorar-qualitat-presa-decisions-lanalisi-decisio-multicriteri-admc\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2020\/01\/28\/millorar-qualitat-presa-decisions-lanalisi-decisio-multicriteri-admc\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Millorar en la qualitat de la presa de decisions amb l&#8217;an\u00e0lisi de decisi\u00f3 multicriteri (ADMC)\",\"datePublished\":\"2020-01-28T10:42:53+00:00\",\"dateModified\":\"2020-01-28T10:42:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2020\/01\/28\/millorar-qualitat-presa-decisions-lanalisi-decisio-multicriteri-admc\/\"},\"wordCount\":766,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2020\/01\/28\/millorar-qualitat-presa-decisions-lanalisi-decisio-multicriteri-admc\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"ADMC\",\"an\u00e0lisi de decisi\u00f3 multicriteri\",\"COFB\",\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"farmac\u00e8utics\",\"farmac\u00e8utics comunitaris\",\"Farm\u00e0cia\",\"farm\u00e0cia comunit\u00e0ria\",\"farm\u00e0cia hospital\u00e0ria\",\"Formaci\u00f3\",\"futur\",\"Oficina de farm\u00e0cia\",\"pacients\",\"presa de decisions\",\"proc\u00e9s de presa de decisions\",\"recursos\",\"Reptes\",\"reptes de futur\",\"Sistema Nacional de Salut\",\"teoria de la decisi\u00f3\"],\"articleSection\":[\"Destacats\",\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2020\/01\/28\/millorar-qualitat-presa-decisions-lanalisi-decisio-multicriteri-admc\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2020\/01\/28\/millorar-qualitat-presa-decisions-lanalisi-decisio-multicriteri-admc\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2020\/01\/28\/millorar-qualitat-presa-decisions-lanalisi-decisio-multicriteri-admc\/\",\"name\":\"Millorar en la qualitat de la presa de decisions amb l'an\u00e0lisi de decisi\u00f3 multicriteri (ADMC) - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2020\/01\/28\/millorar-qualitat-presa-decisions-lanalisi-decisio-multicriteri-admc\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2020\/01\/28\/millorar-qualitat-presa-decisions-lanalisi-decisio-multicriteri-admc\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2020-01-28T10:42:53+00:00\",\"dateModified\":\"2020-01-28T10:42:53+00:00\",\"description\":\"El passat 17 de gener va tenir lloc al Col\u00b7legi de Farmac\u00e8utics de Barcelona la formaci\u00f3 \\\"An\u00e0lisi de decisi\u00f3 multicriteri\\\" (ADMC).\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2020\/01\/28\/millorar-qualitat-presa-decisions-lanalisi-decisio-multicriteri-admc\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2020\/01\/28\/millorar-qualitat-presa-decisions-lanalisi-decisio-multicriteri-admc\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/novaorg.cofb.net\/2020\/01\/28\/millorar-qualitat-presa-decisions-lanalisi-decisio-multicriteri-admc\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2020\/01\/28\/millorar-qualitat-presa-decisions-lanalisi-decisio-multicriteri-admc\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Millorar en la qualitat de la presa de decisions amb l&#8217;an\u00e0lisi de decisi\u00f3 multicriteri (ADMC)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Millorar en la qualitat de la presa de decisions amb l'an\u00e0lisi de decisi\u00f3 multicriteri (ADMC) - Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"El passat 17 de gener va tenir lloc al Col\u00b7legi de Farmac\u00e8utics de Barcelona la formaci\u00f3 \"An\u00e0lisi de decisi\u00f3 multicriteri\" (ADMC).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2020\/01\/28\/millorar-qualitat-presa-decisions-lanalisi-decisio-multicriteri-admc\/","og_locale":"es_ES","og_type":"article","og_title":"Millorar en la qualitat de la presa de decisions amb l'an\u00e0lisi de decisi\u00f3 multicriteri (ADMC) - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"El passat 17 de gener va tenir lloc al Col\u00b7legi de Farmac\u00e8utics de Barcelona la formaci\u00f3 \"An\u00e0lisi de decisi\u00f3 multicriteri\" (ADMC).","og_url":"https:\/\/novaorg.cofb.net\/2020\/01\/28\/millorar-qualitat-presa-decisions-lanalisi-decisio-multicriteri-admc\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2020-01-28T10:42:53+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrito por":"wpAdminCofbOrg","Tiempo de lectura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2020\/01\/28\/millorar-qualitat-presa-decisions-lanalisi-decisio-multicriteri-admc\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2020\/01\/28\/millorar-qualitat-presa-decisions-lanalisi-decisio-multicriteri-admc\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Millorar en la qualitat de la presa de decisions amb l&#8217;an\u00e0lisi de decisi\u00f3 multicriteri (ADMC)","datePublished":"2020-01-28T10:42:53+00:00","dateModified":"2020-01-28T10:42:53+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2020\/01\/28\/millorar-qualitat-presa-decisions-lanalisi-decisio-multicriteri-admc\/"},"wordCount":766,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2020\/01\/28\/millorar-qualitat-presa-decisions-lanalisi-decisio-multicriteri-admc\/#primaryimage"},"thumbnailUrl":"","keywords":["ADMC","an\u00e0lisi de decisi\u00f3 multicriteri","COFB","Col\u00b7legi de Farmac\u00e8utics de Barcelona","farmac\u00e8utics","farmac\u00e8utics comunitaris","Farm\u00e0cia","farm\u00e0cia comunit\u00e0ria","farm\u00e0cia hospital\u00e0ria","Formaci\u00f3","futur","Oficina de farm\u00e0cia","pacients","presa de decisions","proc\u00e9s de presa de decisions","recursos","Reptes","reptes de futur","Sistema Nacional de Salut","teoria de la decisi\u00f3"],"articleSection":["Destacats","M\u00f3n col\u00b7legial"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2020\/01\/28\/millorar-qualitat-presa-decisions-lanalisi-decisio-multicriteri-admc\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2020\/01\/28\/millorar-qualitat-presa-decisions-lanalisi-decisio-multicriteri-admc\/","url":"https:\/\/novaorg.cofb.net\/2020\/01\/28\/millorar-qualitat-presa-decisions-lanalisi-decisio-multicriteri-admc\/","name":"Millorar en la qualitat de la presa de decisions amb l'an\u00e0lisi de decisi\u00f3 multicriteri (ADMC) - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2020\/01\/28\/millorar-qualitat-presa-decisions-lanalisi-decisio-multicriteri-admc\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2020\/01\/28\/millorar-qualitat-presa-decisions-lanalisi-decisio-multicriteri-admc\/#primaryimage"},"thumbnailUrl":"","datePublished":"2020-01-28T10:42:53+00:00","dateModified":"2020-01-28T10:42:53+00:00","description":"El passat 17 de gener va tenir lloc al Col\u00b7legi de Farmac\u00e8utics de Barcelona la formaci\u00f3 \"An\u00e0lisi de decisi\u00f3 multicriteri\" (ADMC).","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2020\/01\/28\/millorar-qualitat-presa-decisions-lanalisi-decisio-multicriteri-admc\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2020\/01\/28\/millorar-qualitat-presa-decisions-lanalisi-decisio-multicriteri-admc\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/novaorg.cofb.net\/2020\/01\/28\/millorar-qualitat-presa-decisions-lanalisi-decisio-multicriteri-admc\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2020\/01\/28\/millorar-qualitat-presa-decisions-lanalisi-decisio-multicriteri-admc\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Millorar en la qualitat de la presa de decisions amb l&#8217;an\u00e0lisi de decisi\u00f3 multicriteri (ADMC)"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"El passat 17 de gener va tenir lloc al Col\u00b7legi de Farmac\u00e8utics de Barcelona la formaci\u00f3 &#8220;An\u00e0lisi de decisi\u00f3 multicriteri&#8221; (ADMC), a c\u00e0rrec de Miguel \u00c1ngel Casado, doctor en Farm\u00e0cia per la Universitat Complutense de Madrid, director de Pharmacoeconomics &amp; Outcomes Research Iberia (PORIB), professor universitari, membre del consell de [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/49339","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/comments?post=49339"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/49339\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/media?parent=49339"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/categories?post=49339"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/tags?post=49339"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}